Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/14/2007EP1853573A1 Benzisothiazoles useful for treating or preventing hcv infection
11/14/2007EP1853572A1 Fluorinated phno and analogs thereof
11/14/2007EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007EP1853569A1 Ligands for g-protein coupled receptors
11/14/2007EP1853568A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives
11/14/2007EP1853567A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
11/14/2007EP1853566A1 Cinnoline compounds and their use as liver x receptor modulators
11/14/2007EP1853564A1 Novel quinoline derivatives as potassium ion channel openers
11/14/2007EP1853563A1 Salt of montelukast with tert.-butylamine
11/14/2007EP1853561A1 PROCESS FOR PRODUCING POLYMORPH FORM (I) OF l-BENZYL-4- [(5, 6-DIMETHOXY-l-INDANONE) -2YL]METHYL PIPERIDINE HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)
11/14/2007EP1853560A1 Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications
11/14/2007EP1853556A1 Derivatives of aminobutanoic acid inhibiting cpt
11/14/2007EP1853555A1 Anthranilic acid derivatives active at the hm74a receptor
11/14/2007EP1853553A1 Substituted hydroxyethylamines
11/14/2007EP1853552A2 Diastereoisomers of 4-hydroxyisoleucine and uses thereof
11/14/2007EP1853538A2 Modulator
11/14/2007EP1853352A2 Use of 3-sulfanylpropanamide derivatives for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof
11/14/2007EP1853349A1 Composition for treating mental health disorders
11/14/2007EP1853319A1 Use of aromatic flavouring agents with high melting point as solubilizing agents
11/14/2007EP1853317A2 Compositions and methods for treating or preventing flaviviridae infections
11/14/2007EP1853316A1 Use of an antagonist of epac for treating human cardiac hypertrophy
11/14/2007EP1853315A1 Treatment for mucositis
11/14/2007EP1853303A1 Stabilized compositions for topical administration and methods of making same
11/14/2007EP1853302A2 Antiangiogenic agents with aldesleukin
11/14/2007EP1853300A2 Methods of using death receptor agonists and egfr inhibitors
11/14/2007EP1853280A2 Compositions and methods for treating and preventing cardiomyopathy and heart disease
11/14/2007EP1853279A1 Amide derivatives of hyaluronic acid in osteoarthrosis
11/14/2007EP1853278A1 Glucosamine materials
11/14/2007EP1853277A1 Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors
11/14/2007EP1853276A2 Compounds inhibiting the aggregation of superoxide dismutase-1
11/14/2007EP1853275A1 Formulations of pyridoxal -5'-phosphate and methods of preparation
11/14/2007EP1853274A2 2-methylene-19-nor- (20s-24s) - 1alpha, 25-d hydroxyvitamine-d2
11/14/2007EP1853273A1 Pharmaceutical composition for contraception
11/14/2007EP1853272A1 Compositions of unconjugated estrogens and methods for their use
11/14/2007EP1853271A2 Method and composition for treating peripheral vascular diseases
11/14/2007EP1853270A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
11/14/2007EP1853269A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
11/14/2007EP1853268A1 Use of sodium channel blockers and their analogues for the treatment of nicotine dependency
11/14/2007EP1853267A1 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof
11/14/2007EP1853266A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions
11/14/2007EP1853265A2 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
11/14/2007EP1853264A1 Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes
11/14/2007EP1853263A1 Compositions and methods for treating dyslipidemia
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853261A1 Selective inhibitors of human corticosteroid synthases
11/14/2007EP1853260A1 Substituted pyrazoles as modulators of chemokine receptors
11/14/2007EP1853259A1 Formulations for ocular treatment
11/14/2007EP1853258A2 Medicaments
11/14/2007EP1853257A2 Pyrazole compounds
11/14/2007EP1853256A2 Organic compounds
11/14/2007EP1853255A1 Methods for treating arthritis using triheterocyclic compounds
11/14/2007EP1853254A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/14/2007EP1853253A1 Diosmetin derivatives for the treatment and prevention of thrombotic pathologies
11/14/2007EP1853252A1 Compositions containing polysaccharides
11/14/2007EP1853251A2 Boron-containing small molecules
11/14/2007EP1853250A1 Combinations and modes of administration of therapeutic agents and combination therapy
11/14/2007EP1853249A2 A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
11/14/2007EP1853248A1 Salts, addition compounds and complex compounds of guanidinoacetic acid
11/14/2007EP1853247A2 Soap scent patch and treatment for muscle spasm and pain
11/14/2007EP1853246A1 L-aspartic acid for the treatment of problems in connection with the fat or glucose metabolism
11/14/2007EP1853245A2 Formulations of suberoylanilide hydroxamic acid and methods for producing same
11/14/2007EP1853244A2 Method for the treatment of retinopathy of prematurity and related retinopathic diseases
11/14/2007EP1853243A2 Treatment of hyperproliferative diseases with anthraquinones
11/14/2007EP1853242A2 Small molecule inhibitors of stat3 and the uses thereof
11/14/2007EP1853241A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3- cyclohexanedione in the treatment of parkinson's disease
11/14/2007EP1853240A2 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
11/14/2007EP1853239A1 Use of zeaxanthin for the treatment of diseases of the peripheral retina
11/14/2007EP1853238A2 Pharmaceutical formulations containing 17-allylamino-17-demethoxygeldanamycin
11/14/2007EP1853237A2 Substances, compositions and methods for treating alopecia
11/14/2007EP1853236A1 Tablets comprising a biologically active substance and an excipient containing calcium carbonate
11/14/2007EP1853235A1 Methods for improving drug disposition
11/14/2007EP1853232A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them
11/14/2007EP1853230A2 Dosage form and method for sustained release of a substituted pyrazine compound
11/14/2007EP1853225A1 Solid dispersion of hydrophobic bioactive
11/14/2007EP1853221A2 Devices for delivering agents to a vaginal tract
11/14/2007EP1853220A1 Production process for nsaid-containing lozenges, their compositions, their medicinal use
11/14/2007EP1853218A2 Trofosfamide-containing film-coated tablets and method for the production thereof
11/14/2007EP1853216A2 Cosmetic and cosmeceutical compositions for restoration of skin barrier function
11/14/2007EP1853213A1 Method and composition for treatment of a mucosal tissure disorder
11/14/2007EP1824485A4 Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents
11/14/2007EP1809328A4 Compositions having body fat reducing function and food and drink containing the same
11/14/2007EP1761529B1 Pyrrolopyridine derivatives and their use as crth2 antagonists
11/14/2007EP1758871B1 Pyrazolo pyrimidines
11/14/2007EP1716147B1 Diaza-spiropiperidine derivatives as inhibitors of glycine transporter 1 and glycine transporter 2
11/14/2007EP1709193A4 Methods and materials for assessing prostate cancer therapies
11/14/2007EP1696909B1 Benzothiazole derivatives for the treatment of diabetes
11/14/2007EP1687006B1 Pharmaceutical compositions for the treatment of renal dysfunction
11/14/2007EP1669379B1 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
11/14/2007EP1668003B1 Benzisoxazoles
11/14/2007EP1664058B1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1654261B1 Hepatitis c inhibitor compounds
11/14/2007EP1633765B1 Novel 14 and 15 membered-ring compounds
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1545709B1 Neoadjuvant treatment of breast cancer
11/14/2007EP1539756B1 Imidazopyridines as cyclin dependent kinase inhibitors
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
1 ... 3504 3505 3506 3507 3508 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 ... 7860